US Broker Ratings

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 20% Upside Potential and Solid Dividend Yield

Grifols, S.A. (NASDAQ: GRFS), a key player in the healthcare sector, is drawing investor attention with its potential for a 20.13% upside, according to analyst consensus. The Spanish drug manufacturer,..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Exploring a 27.41% Potential Upside in the Healthcare Sector

Prestige Consumer Healthcare Inc. (NYSE: PBH) is an intriguing player in the healthcare sector, specializing in over-the-counter (OTC) health and personal care products. With a market capitalization of $3.01 billion,..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Evaluating a 50% Upside Potential Amidst Biotech Innovations

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands at a pivotal junction in the biotechnology sector, boasting a market capitalization of $11.42 billion. As a leader in the development and commercialization of..

Elanco Animal Health (ELAN) Stock Analysis: Exploring a 11% Potential Upside for Investors

Elanco Animal Health Incorporated (NYSE: ELAN) stands out as a major player in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing for animals. Based in..

Novo Nordisk A/S (NVO) Stock Analysis: Evaluating the 71.47% Return on Equity in the Healthcare Sector

Novo Nordisk A/S (NYSE: NVO), a dominant force in the healthcare sector, stands out not only for its impressive market capitalization of $232.79 billion but also for a remarkable return..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unveiling a 180% Potential Upside in Radiopharmaceutical Innovation

Investors seeking opportunities in the biotechnology sector might find Telix Pharmaceuticals Limited (ASX: TLX) an intriguing prospect. With a focus on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals,..

United Therapeutics Corporation (UTHR) Stock Analysis: A Healthcare Giant with Strong Growth Potential and Robust Analyst Support

United Therapeutics Corporation (NASDAQ: UTHR) stands out in the healthcare sector, particularly within the specialized and generic drug manufacturing industry. With a market capitalization of $22.46 billion, this biotech company..

Hologic, Inc. (HOLX) Stock Analysis: Evaluating the 2.6% Potential Upside Amid Strong Revenue Growth

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector with a focus on medical instruments and supplies, presents an intriguing opportunity for investors. With a market capitalization of..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a Potential 235% Upside in the Booming Biotech Sector

Legend Biotech Corporation (NASDAQ: LEGN), a promising player in the biopharmaceutical landscape, is capturing attention with its groundbreaking work in cell therapies aimed at treating cancer. With a market capitalization..

ADMA Biologics (ADMA): Analyst Consensus Points to a 43.55% Upside Potential in Biotech

ADMA Biologics Inc (NASDAQ: ADMA) stands out in the biotech sector with a significant promise of growth and development. Founded in 2004 and headquartered in Ramsey, New Jersey, ADMA is..

Incyte Corporation (INCY): Stock Analysis Highlights Strong Revenue Growth and Robust Pipeline

Incyte Corporation (NASDAQ: INCY), a notable player in the biotechnology sector, has been making waves with its impressive revenue growth and promising drug pipeline. With a market capitalization of $19.91..

Natera, Inc. (NTRA) Investor Outlook: Exploring a $31.91 Billion Market Cap and 8.53% Potential Upside

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare sector, specifically within diagnostics and research, has captured investor attention with its dynamic approach to molecular testing services. Headquartered in..

Insmed Incorporated (INSM) Stock Analysis: Strong Buy Ratings and Promising Growth Trajectory

Insmed Incorporated (NASDAQ: INSM) continues to capture investor attention in the healthcare sector, particularly in the biotechnology industry, where it stands out with a significant market capitalization of $37.77 billion...

Bio-Techne Corp (TECH): Investor Outlook on a Stock Poised for 16.79% Upside

Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the healthcare sector, is capturing investor attention with analysts forecasting a potential 16.79% upside. With its market capitalization standing strong at $9.29..

Royalty Pharma plc (RPRX): Investor Outlook with a 19% Upside Potential

Royalty Pharma plc (NASDAQ: RPRX) stands out in the biotechnology sector with its unique business model of acquiring biopharmaceutical royalties and funding innovation. As it rides the wave of the..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 15% Upside Potential

In the dynamic landscape of the healthcare sector, Align Technology, Inc. (NASDAQ: ALGN) stands out as a formidable player in the Medical Instruments & Supplies industry. Headquartered in Tempe, Arizona,..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a 39% Potential Upside in the Medical Instruments Sector

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is capturing investor attention with its significant growth potential. Headquartered..

CVS Health Corporation (CVS) Stock Analysis: Evaluating an 18% Potential Upside Amid Strong Buy Ratings

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, continues to captivate investors with its expansive reach and robust market presence. With a current market capitalization of $101.72..

Waystar Holding Corp. (WAY) Stock Analysis: Unlocking a 54% Potential Upside

For investors keen on exploring opportunities in the healthcare sector, Waystar Holding Corp. (NASDAQ: WAY) presents a compelling case with a striking potential upside of 54.13%. Headquartered in Lehi, Utah,..

Illumina, Inc. (ILMN) Stock Analysis: Can This Genomics Leader Defy Its Potential Downside?

Illumina, Inc. (NASDAQ: ILMN) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in San Diego, California, Illumina’s core business revolves around providing..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds